The Food and Drug Administration (FDA) has approved Arbli™, an oral suspension formulation of losartan potassium. Arbli, an angiotensin II receptor blocker, is indicated for the treatment of ...
Hosted on MSN5mon
FDA recalls more than 7,000 bottles of antidepressant over a possible cancerous chemicalThe recall was initiated earlier this month ... More than 12 million bottles of blood pressure-lowering drugs such as valsartan and losartan have been removed from the market since 2018 because ...
This resulted in additional recalls of Valsartan, and losartan-containing products found ... This dramatic increase in incidences of drug contamination and the subsequent product recalls are ...
Arbli is supplied as an peppermint-flavored oral suspension containing 10mg/mL of losartan potassium in 165mL bottles. The Food and Drug Administration (FDA) has approved Arbli ™, an oral ...
Hosted on MSN3mon
FDA recalls more than 233,000 bottles of antidepressant over possible cancerous chemicalLooking for more recalls? Check out USA TODAY's recall ... More than 12 million bottles of blood pressure-lowering drugs such as valsartan and losartan have been removed from the market since ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback